SC: Centre's nod for Remdesivir and Favipiravir for Covid-19, asks petitioner to study rules
Published By : Prameya News Bureau | September 16, 2020 IST
Share
New Delhi, Sep 16: The Supreme Court on Wednesday said the Centre has framed rules on drugs clinical trial and there is also an approval on the use of Remdesivir and Favipiravir as medicines to treat Covid-19.A bench headed by Chief Justice S A Bobde and comprising Justices A S Bopanna and V Ramasubramanian, citing the New Drugs and Clinical Trials Rules, 2018, said these medicines have been permitted by the government for the Covid-19 pandemic situation.The observation came from the top court while hearing a plea a seeking CBI probe against 10 pharma companies selling these medicines allegedly as a treatment for Covid-19 patients without valid licences.Both Remdesivir and Favipiravir are antiviral drugs and their clinical efficacy in the treatment of the Covid-19 viral infection is a matter of debate.The bench told the petitioner that it seems he has not noticed New Drugs and Clinical Trials Rules and filed this plea before the court. "You may see the rules and come back to the court. We are adjourning this matter", the bench told advocate M L Sharma, who filed this plea.The bench has adjourned the matter for two weeks.The plea contended," That respondent no.3 to 10 are Indian pharmaceutical company who have signed partnership agreements with foreign companies that are Gilead Science Inc -USA and Fujifilm Japan, to manufacture and sale impugned drug, Remdesivir and Avagin (Favipiravir) in India. Without having a licence, they are manufacturing and selling impugned drugs as a medicine for corona in India."Seeking a CBI probe, the petitioner alleged that these two medicines have been wrongly manufactured and sold in the garb of treatment for Covid-19 patients without any valid licences from the Central Drugs Standard Control Organisation.The petitioner sought prosecution of Indian companies for offences of cheating and criminal conspiracy besides under the provisions of the Drug Act, 1940. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
LS poll: BJP nominates Narayan Rane from Ratnagiri Sindhudurg
ED attaches Shilpa Shetty and Raj Kundra's assets worth Rs 98 Cr
FIR filed against woman accusing Ravi Kishan is father of her daughter
Kashi sculptor's replica of Ram Lalla idol for Netherlands Temple
Lok Sabha polls: More rallies, roadshows planned for PM Modi in UP
Over 25 Million voters set to cast ballots in Rajasthan's first phase of Lok Sabha Elections
Political controversy erupts over attack on youths chanting 'Jai Shri Ram' in Bengaluru
Odisha-Chhattisgarh border on high alert after Kanker encounter
ECoR to run 40 Summer Special trains
Boys born to mothers with HIV more vulnerable to death in infancy
'Their govt is for 20-25 select people...', Rahul Gandhi's jibe at BJP in Karnataka rally
Bihar man shot dead by terrorists in J&K's Anantnag
Campaign ends for first phase of LS polls in Assam
Delhi HC recognises Central Delhi Court Bar Association for Rouse Avenue courts
Ajay Banga, Satya Nadella, Alia Bhat, Sakshi Malik on TIME Magazine's 100 Most Influential People list
Violence reported from Cooch Behar as campaigning ends for Phase 1 of Lok Sabha polls
Swabhimani Odia Women’s World celebrates Odia New Year in Delhi, Mumbai: Enjoys Pana Sankranti with bael juice & typical Odia events
PIL in SC seeks expert panel to examine feasibility of 3-yr LLB immediately after Class 12
World Hemophilia Day: Solidarity for people living with rare genetic disorder
PM Modi watches mesmerizing Surya Tilak event of Ram Lalla LIVE